A New Era in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis.
作者信息
Tazawa Ryushi, Nakata Koh
机构信息
Student Healthcare Centre, Institute of Science Tokyo, Tokyo, Japan.
Niigata University Medical and Dental Hospital, Niigata, Japan.
出版信息
Respirology. 2025 Jun;30(6):463-465. doi: 10.1111/resp.70048. Epub 2025 Apr 29.
Abstract
摘要
相似文献
1
A New Era in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis.
Respirology. 2025 Jun;30(6):463-465. doi: 10.1111/resp.70048. Epub 2025 Apr 29.
2
[Patient with autoimmune alveolar proteinosis who did not respond to GM-CSF inhalation therapy and underwent repeated whole-lung lavage].
Nihon Kokyuki Gakkai Zasshi. 2009 Sep;47(9):833-8.
3
Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis.
Respir Med. 2012 Feb;106(2):284-93. doi: 10.1016/j.rmed.2011.10.019. Epub 2011 Nov 22.
4
Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.
N Engl J Med. 2019 Sep 5;381(10):923-932. doi: 10.1056/NEJMoa1816216.
5
GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis.
N Engl J Med. 2007 Feb 8;356(6):567-79. doi: 10.1056/NEJMoa062505.
6
Pulmonary alveolar proteinosis: time to shift?
Expert Rev Respir Med. 2015 Jun;9(3):337-49. doi: 10.1586/17476348.2015.1035259. Epub 2015 Apr 12.
7
Nebulised granulocyte-macrophage colony-stimulating factor (GM-CSF) in autoimmune pulmonary alveolar proteinosis: a systematic review and meta-analysis.
Eur Respir Rev. 2023 Nov 22;32(170). doi: 10.1183/16000617.0080-2023. Print 2023 Dec 31.
8
Inhaled granulocyte-macrophage colony stimulating factor for mild-to-moderate autoimmune pulmonary alveolar proteinosis - a six month phase II randomized study with 24 months of follow-up.
Orphanet J Rare Dis. 2020 Jul 2;15(1):174. doi: 10.1186/s13023-020-01450-4.
9
B cell-activating factors in autoimmune pulmonary alveolar proteinosis.
Orphanet J Rare Dis. 2021 Mar 2;16(1):115. doi: 10.1186/s13023-021-01755-y.
10
Better approach for autoimmune pulmonary alveolar proteinosis treatment: inhaled or subcutaneous granulocyte-macrophage colony-stimulating factor: a meta-analyses.
Respir Res. 2018 Aug 31;19(1):163. doi: 10.1186/s12931-018-0862-4.
本文引用的文献
1
Repeated inhalation of GM-CSF by nonhuman primates induces bronchus-associated lymphoid tissue along the lower respiratory tract.
Respir Res. 2024 Nov 10;25(1):402. doi: 10.1186/s12931-024-03003-w.
2
Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patients.
Eur Respir J. 2024 Jan 4;63(1). doi: 10.1183/13993003.01233-2023. Print 2024 Jan.
3
Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis.
N Engl J Med. 2020 Oct 22;383(17):1635-1644. doi: 10.1056/NEJMoa1913590. Epub 2020 Sep 7.
4
Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.
N Engl J Med. 2019 Sep 5;381(10):923-932. doi: 10.1056/NEJMoa1816216.
5
Sequential Granulocyte-Macrophage Colony-Stimulating Factor Inhalation after Whole-Lung Lavage for Pulmonary Alveolar Proteinosis. A Report of Five Intractable Cases.
Ann Am Thorac Soc. 2017 Aug;14(8):1298-1304. doi: 10.1513/AnnalsATS.201611-892BC.
6
Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled granulocyte-macrophage colony-stimulating factor therapy.
Chest. 2014 Apr;145(4):729-737. doi: 10.1378/chest.13-0603.
7
Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis.
Am J Respir Crit Care Med. 2010 Jun 15;181(12):1345-54. doi: 10.1164/rccm.200906-0978OC. Epub 2010 Feb 18.
8
An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis.
Chest. 2006 Jul;130(1):227-37. doi: 10.1378/chest.130.1.227.
9
Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis.
Eur Respir J. 2006 Mar;27(3):585-93. doi: 10.1183/09031936.06.00058305.
10
Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report.
Respirology. 2006 Jan;11 Suppl:S61-4. doi: 10.1111/j.1440-1843.2006.00811.x.
Zotero 插件